癌相关成纤维细胞在肿瘤葡萄糖代谢中的作用

doi:10.19438/j.cjoms.2021.01.014

摘要/Abstract

摘要： 瓦博格效应认为,即便在氧气充足时,肿瘤仍大量利用葡萄糖进行有氧糖酵解,产生乳酸和少量ATP。虽产能效率低,但中间产物有利于改造肿瘤微环境,促进肿瘤恶性进展。近年发现,成纤维细胞作为肿瘤间质的重要组成部分,在肿瘤细胞诱导下具有癌相关成纤维细胞（cancer-associated fibroblast, CAF）表型,通过自身线粒体功能障碍、自噬而持续向肿瘤细胞提供生物大分子合成原料,用以促进肿瘤增殖、侵袭、转移、耐药。相反,肿瘤细胞自身则提高线粒体代谢水平,进行氧化磷酸化,此现象被命名为反瓦博格效应。CAF与酸化的微环境驱动肿瘤细胞自发选择葡萄糖代谢方式、促进肿瘤恶性进展。

关键词: 癌相关成纤维细胞, 糖酵解, 瓦博格效应, 肿瘤微环境

Abstract: ] Warburg effect described a phenomenon that tumor cells undergoing aerobic glycolysis even with enough oxygen, generating lactic acid and little ATP. Although it had a low efficiency of energy production, lactic acid and other products may work as intermediates to modify tumor microenvironment and promote tumor progression. Recently, it's reported that fibroblasts, an important part of tumor stroma, were endowed with cancer-associated fibroblast (CAF) phenotype such as undergoing aerobic glycolysis, mitophagy and mitochondrial dysfunction. CAF provided lactic acid and other intermediates as building blocks for macromolecule anabolism, which could facilitate tumor proliferation, invasion, metastasis and drug resistance. On the contrary, tumor cells obtained activated oxidative phosphorylation and mitochondrial metabolism, which was named as "reverse Warburg effect". The two theory unveiled a metabolic flexibility and cross-talk among tumor cells and acidic tumor microenvironment, which facilitates tumor progression.

Key words: Cancer-associated fibroblast, Glycolysis, Warburg effect, Tumor microenvironment

中图分类号:

R739.8

李明彧, 马海龙, 杨溪, 张志愿. 癌相关成纤维细胞在肿瘤葡萄糖代谢中的作用[J]. 中国口腔颌面外科杂志, 2021, 19(1): 70-75.

LI Ming-yu, MA Hai-long, YANG Xi, ZHANG Zhi-yuan. The effect of cancer-associated fibroblast in glucose metabolism of tumor cells[J]. China J Oral Maxillofac Surg, 2021, 19(1): 70-75.

参考文献

[1] Xing Y, Zhao S, Zhou BP, et al.Metabolic reprogramming of the tumour microenvironment[J]. FEBS J, 2015, 282(20): 3892-3898.
[2] Deberardinis RJ, Chandel NS.Fundamentals of cancer metabolism[J]. Sci Adv, 2016, 2(5): e1600200.
[3] Martinez-Outschoorn UE, Lin Z, Trimmer C, et al.Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors[J]. Cell Cycle, 2011, 10(15): 2504-2520.
[4] 周美玲, 李传祝, 王琼, 等. 人口腔癌相关成纤维细胞的分离培养及鉴定[J]. 口腔生物医学, 2016, 7(2): 57-61.
[5] Lisanti MP, Martinez-Outschoorn UE, Sotgia F.Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery[J]. Cell Cycle, 2013, 12(17): 2723-2732.
[6] Knudsen ES, Balaji U, Freinkman E, et al.Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential[J]. Oncotarget, 2016, 7(48): 78396-78411.
[7] Fiaschi T, Giannoni E, Taddei ML, et al.Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells[J]. Cell Cycle, 2013, 12(11): 1791-1801.
[8] Salem AF, Whitaker-Menezes D, Lin Z, et al.Two-compartment tumor metabolism: Autophagy in the tumor microenvironment, and oxidative mitochondrial metabolism (OXPHOS) in cancer cells[J]. Cell Cycle, 2012, 11(13): 2545-2556.
[9] Apicella M, Giannoni E, Fiore S, et al. Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies [J]. Cell Metab, 2018, 28(6): 848-865.e846.
[10] Radhakrishnan R, Ha JH, Jayaraman M, et al.Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts[J]. Cancer Lett, 2019, 442: 464-474.
[11] Yan W, Wu X, Zhou W, et al.Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells[J]. Nat Cell Biol, 2018, 20(5): 597-609.
[12] Zhao L, Ji G, Le X, et al.Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer[J]. Cancer Res, 2017, 77(6): 1369-1382.
[13] Peiris-Pagès M, Sotgia F, Lisanti MP.Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells[J]. Oncotarget, 2015, 6(13): 10728-10745.
[14] Martinez-Outschoorn UE, Lisanti MP, Sotgia F.Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth[J]. Semin Cancer Biol, 2014, 25: 47-60.
[15] Nguyen T, Kirsch J, Nabi K, et al.Effects of carcinoma-associated fibroblasts on cancer metabolism [A]. Philadelphia: Proceedings of the American Association for Cancer Research Annual Meeting, 2018.
[16] Ueno T, Utsumi J, Toi M, et al.Characteristic gene expression profiles of human fibroblasts and breast cancer cells in a newly developed bilateral coculture system[J]. Biomed Res Int, 2015, 2015: 960840.
[17] Giannoni E, Taddei ML, Morandi A, et al.Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread[J]. Oncotarget, 2015, 6(27): 24061-24074.
[18] Fiaschi T, Marini A, Giannoni E, et al.Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay[J]. Cancer Res, 2012, 72(19): 5130-5140.
[19] Luo M, Luo Y, Mao N, et al.Cancer-associated fibroblasts accelerate malignant progression of non-small cell lung cancer via connexin 43-formed unidirectional gap junctional intercellular communication[J]. Cell Physiol Biochem, 2018, 51(1): 315-336.
[20] Capparelli C, Chiavarina B, Whitaker-Menezes D, et al.CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis[J]. Cell Cycle, 2012, 11(19): 3599-3610.
[21] Shangguan C, Gan G, Zhang J, et al.Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT[J]. Theranostics, 2018, 8(5): 1376-1388.
[22] Zhao H, Yang L, Baddour J, et al.Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism[J]. Elife, 2016, 5: e10250.
[23] Druzhkova IN, Shirmanova MV, Lukina MM, et al.The metabolic interaction of cancer cells and fibroblasts-coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide[J]. Cell Cycle, 2016, 15(9): 1257-1266.
[24] Pavlides S, Whitaker-Menezes D, Castello-Cros R, et al.The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma[J]. Cell Cycle, 2009, 8(23): 3984-4001.
[25] Dumont J.Cancer heterogeneity is incompatible with a unique cell metabolic map[J]. Eur J Cancer, 2016, 61(1): S165-S165.
[26] Fiori ME, Di Franco S, Villanova L, et al.Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance[J]. Mol Cancer, 2019, 18(1): 70-86.
[27] He Z, You C, Zhao D.Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells[J]. Biochem Biophys Res Commun, 2018, 500(3): 569-576.
[28] Wanandi SI, Ningsih SS, Asikin H, et al.Metabolic interplay between tumour cells and cancer-associated fibroblasts (CAFs) under hypoxia versus normoxia[J]. Malays J Med Sci, 2018, 25(3): 7-16.
[29] Yang L, Pang Y, Moses HL.TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression[J]. Trends Immunol, 2010, 31(6): 220-227.
[30] Saunier EF, Akhurst RJ.TGF beta inhibition for cancer therapy[J]. Curr Cancer Drug Targets, 2006, 6(7): 565-578.
[31] Turley SJ, Cremasco V, Astarita JL.Immunological hallmarks of stromal cells in the tumour microenvironment[J]. Nat Rev Immunol, 2015, 15(11): 669-682.
[32] Rüegg CR, Chiquet-Ehrismann R, Alkan SS.Tenascin, an extracellular matrix protein, exerts immunomodulatory activities[J]. Proc Natl Acad Sci USA, 1989, 86(19): 7437-7441.
[33] Brand A, Singer K, Koehl GE, et al.LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells[J]. Cell Metab, 2016, 24(5): 657-671.
[34] Lim SO, Li CW, Xia W, et al.EGFR Signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape[J]. Cancer Res, 2016, 76(5): 1284-1296.
[35] Gabrilovich DI, Nagaraj S.Myeloid-derived suppressor cells as regulators of the immune system[J]. Nat Rev Immunol, 2009, 9(3): 162-174.
[36] Norian LA, Rodriguez PC, O'mara LA, et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism[J]. Cancer Res, 2009, 69(7): 3086-3094.
[37] Kareva I, Hahnfeldt P.The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?[J]. Cancer Res, 2013, 73(9): 2737-2742.
[38] Maciver NJ, Jacobs SR, Wieman HL, et al.Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival[J]. J Leukoc Biol, 2008, 84(4): 949-957.
[39] Chang CH, Qiu J, O'sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression[J]. Cell, 2015, 162(6): 1229-1241.
[40] Husain Z, Huang Y, Seth P, et al.Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells[J]. J Immunol, 2013, 191(3): 1486-1495.
[41] Sun K, Tang S, Hou Y, et al.Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling[J]. EBioMedicine, 2019, 41: 370-383.
[42] Goulet CR, Champagne A, Bernard G, et al.Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling[J]. BMC Cancer, 2019, 19(1): 137.
[43] Zhu S, Zhou HY, Deng SC, et al.ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca²⁺/RhoA pathway[J]. Cell Death Dis, 2017, 8(5): e2806-e2819.
[44] Suzuki A, Maeda T, Baba Y, et al.Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model[J]. Cancer Cell Int, 2014, 14(1): 129-140.
[45] Chen KH, Tung PY, Wu JC, et al.An acidic extracellular pH induces Src kinase-dependent loss of beta-catenin from the adherens junction[J]. Cancer letters, 2008, 267(1): 37-48.
[46] Chen Y, Chen CH, Tung PY, et al.An acidic extracellular pH disrupts adherens junctions in HepG2 cells by Src kinases-dependent modification of E-cadherin[J]. J Cell Biochem, 2009, 108(4): 851-859.
[47] Bonuccelli G, Tsirigos A, Whitaker-Menezes D, et al.Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism[J]. Cell Cycle, 2010, 9(17): 3506-3514.
[48] Walenta S, Schroeder T, Mueller-Klieser W.Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology[J]. Curr Med Chem, 2004, 11(16): 2195-2204.
[49] Martinez-Outschoorn UE, Lin Z, Ko YH, et al.Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells[J]. Cell Cycle, 2011, 10(15): 2521-2528.
[50] Migneco G, Whitaker-Menezes D, Chiavarina B, et al.Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling[J]. Cell Cycle, 2010, 9(12): 2412-2422.
[51] Price JM, Baker LCJ, Boult JKR, et al.18F-fluorodeoxyglucose (FDG) uptake is increased in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistant compared with sensitive head and neck cancer xenografts[J]. Eur J Nucl Med and Mol Imaging, 2014, 41: S638-S641.
[52] Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, et al.Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells[J]. Cell Cycle, 2010, 9(16): 3256-3276.
[53] Pértega-Gomes N, Vizcaino JR, Attig J, et al.A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer[J]. BMC Cancer, 2014, 14: 352-360.